Black Swan Analysis Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 20
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Black Swan Analysis General Information


Operator of a consultancy firm specializing in asset valuations and epidemiology based in London, United Kingdom. The company provides analysis, modelling and market forecasting, valuations, commercialization plans, lifecycle optimization solutions and strategic insight to companies in the healthcare industry, with a focus on bespoke epidemiology and segmentation serving top pharmaceutical companies, biotech and tech transfer offices.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Primary Office
  • The Place
  • Bridge Avenue
  • Maidenhead SL6 1AF
  • England, United Kingdom
+44 01628 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Black Swan Analysis Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Black Swan Analysis‘s full profile, request access.

Request a free trial

Black Swan Analysis Executive Team (1)

Name Title Board Seat Contact Info
Nic Talbot-Watt Chief Executive Officer, Managing Director, Director of Analysis and Forecasting and Founder
To view Black Swan Analysis’s complete executive team members history, request access »

Black Swan Analysis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial